메뉴 건너뛰기




Volumn 66, Issue 3, 2010, Pages 449-453

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer

Author keywords

Advanced non small cell lung cancer; Carboplatin; Docetaxel; Weekly

Indexed keywords

CARBOPLATIN; DOCETAXEL; ERLOTINIB; GEFITINIB; GEMCITABINE; IRINOTECAN; ANTINEOPLASTIC AGENT; TAXOID;

EID: 77954667020     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1180-9     Document Type: Article
Times cited : (2)

References (29)
  • 2
    • 1242318822 scopus 로고    scopus 로고
    • State-of-the-art chemotherapy for advanced non-small cell lung cancer
    • Ramalingam S, Belani CP (2004) State-of-the-art chemotherapy for advanced non-small cell lung cancer. Semin Oncol 31:68-74
    • (2004) Semin. Oncol. , vol.31 , pp. 68-74
    • Ramalingam, S.1    Belani, C.P.2
  • 3
    • 0037050352 scopus 로고    scopus 로고
    • Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
    • Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92-98
    • (2002) N. Engl. J. Med. , vol.346 , pp. 92-98
    • Schiller, J.H.1    Harrington, D.2    Belani, C.P.3
  • 4
    • 5444235920 scopus 로고    scopus 로고
    • Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer
    • Hotta K, Matsuo K, Ueoka H et al (2004) Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol 22:3852-3859
    • (2004) J. Clin. Oncol. , vol.22 , pp. 3852-3859
    • Hotta, K.1    Matsuo, K.2    Ueoka, H.3
  • 5
    • 34347379142 scopus 로고    scopus 로고
    • Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: An individual patient data meta-analysis
    • Ardizzoni A, Boni L, Tiseo M et al (2007) Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 99:847-857
    • (2007) J. Natl. Cancer Inst. , vol.99 , pp. 847-857
    • Ardizzoni, A.1    Boni, L.2    Tiseo, M.3
  • 6
    • 0028169602 scopus 로고
    • Docetaxel (Taxotere) is active in non-small-cell lung cancer: A phase II trial of the EORTC early clinical trials group (ECTG)
    • Cerny T, Kaplan S, Pavlidis N et al (1994) Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG). Br J Cancer 70:384-387
    • (1994) Br. J. Cancer , vol.70 , pp. 384-387
    • Cerny, T.1    Kaplan, S.2    Pavlidis, N.3
  • 7
    • 0028240902 scopus 로고
    • Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer
    • Francis PA, Rigas JR, Kris MG et al (1994) Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer. J Clin Oncol 12:1232-1237
    • (1994) J. Clin. Oncol. , vol.12 , pp. 1232-1237
    • Francis, P.A.1    Rigas, J.R.2    Kris, M.G.3
  • 8
    • 0029913666 scopus 로고    scopus 로고
    • Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: A Japanese cooperative study
    • Kunitoh H, Watanabe K, Onoshi T et al (1996) Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol 14:1649-1655
    • (1996) J. Clin. Oncol. , vol.14 , pp. 1649-1655
    • Kunitoh, H.1    Watanabe, K.2    Onoshi, T.3
  • 9
    • 23444459189 scopus 로고
    • Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer
    • Fossella FV, Lee JS, Murphy WK et al (1994) Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer. J Clin Oncol 12:1238-1244
    • (1994) J. Clin. Oncol. , vol.12 , pp. 1238-1244
    • Fossella, F.V.1    Lee, J.S.2    Murphy, W.K.3
  • 10
    • 0028944053 scopus 로고
    • Phase II study of docetaxel (Taxotere) for advanced or metastatic platinum-refractory non-small cell lung cancer
    • Fossella FV, Lee JS, Shin DM et al (1995) Phase II study of docetaxel (Taxotere) for advanced or metastatic platinum-refractory non-small cell lung cancer. J Clin Oncol 13:645-651
    • (1995) J. Clin. Oncol. , vol.13 , pp. 645-651
    • Fossella, F.V.1    Lee, J.S.2    Shin, D.M.3
  • 11
    • 0033988085 scopus 로고    scopus 로고
    • Activity of docetaxel in platinum treated non-small-cell lung cancer: Results of a phase II multicenter trial
    • Gandara DR, Vokes E, Green M et al (2000) Activity of docetaxel in platinum treated non-small-cell lung cancer: results of a phase II multicenter trial. J Clin Oncol 18:131-135
    • (2000) J. Clin. Oncol. , vol.18 , pp. 131-135
    • Gandara, D.R.1    Vokes, E.2    Green, M.3
  • 12
    • 0031800526 scopus 로고    scopus 로고
    • Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
    • Hainsworth JD, Burris HA 3rd, Erland JB et al (1998) Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. J Clin Oncol 16:2164-2168
    • (1998) J. Clin. Oncol. , vol.16 , pp. 2164-2168
    • Hainsworth, J.D.1    Burris III, H.A.2    Erland, J.B.3
  • 13
    • 0032815130 scopus 로고    scopus 로고
    • Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
    • Briasoulis E, Karavasilis V, Anastasopoulos D et al (1999) Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration. Ann Oncol 10:701-706
    • (1999) Ann. Oncol. , vol.10 , pp. 701-706
    • Briasoulis, E.1    Karavasilis, V.2    Anastasopoulos, D.3
  • 14
    • 0033735209 scopus 로고    scopus 로고
    • Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
    • Belani CP, Einzig A, Bonomi P et al (2000) Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer. Ann Oncol 11:673-678
    • (2000) Ann. Oncol. , vol.11 , pp. 673-678
    • Belani, C.P.1    Einzig, A.2    Bonomi, P.3
  • 15
    • 0037348549 scopus 로고    scopus 로고
    • Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
    • Millward MJ, Boyer MJ, Lehnert M et al (2003) Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 14:449-454
    • (2003) Ann. Oncol. , vol.14 , pp. 449-454
    • Millward, M.J.1    Boyer, M.J.2    Lehnert, M.3
  • 16
    • 0042413836 scopus 로고    scopus 로고
    • Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
    • Fossella F, Pereira JR, von Pawel J et al (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016-3024
    • (2003) J. Clin. Oncol. , vol.21 , pp. 3016-3024
    • Fossella, F.1    Pereira, J.R.2    Von Pawel, J.3
  • 17
    • 0024536437 scopus 로고
    • Optimal two-stage designs for phase II clinical trials
    • Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10
    • (1989) Control Clin. Trials , vol.10 , pp. 1-10
    • Simon, R.1
  • 18
    • 0035021152 scopus 로고    scopus 로고
    • A phase II study of docetaxel and carboplatin in the treatment of nonsmall cell lung cancer
    • Zarogoulidis K, Kontakiotis T, Hatziapostolou P et al (2001) A phase II study of docetaxel and carboplatin in the treatment of nonsmall cell lung cancer. Lung Cancer 32:281-287
    • (2001) Lung Cancer , vol.32 , pp. 281-287
    • Zarogoulidis, K.1    Kontakiotis, T.2    Hatziapostolou, P.3
  • 20
    • 33750743388 scopus 로고    scopus 로고
    • A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer
    • Kasahara K, Kimura H, Shibata K et al (2006) A phase II study of combination chemotherapy with docetaxel and carboplatin for patients with advanced or metastatic non-small cell lung cancer. Anticancer Res 26:3723-3728
    • (2006) Anticancer Res. , vol.26 , pp. 3723-3728
    • Kasahara, K.1    Kimura, H.2    Shibata, K.3
  • 22
    • 0034661693 scopus 로고    scopus 로고
    • Weekly docetaxel in the treatment of elderly patients will advanced nonsmall cell lung carcinoma: A Minnie Pearl Cancer Research Network Phase II Trial
    • DOI 10.1002/1097-0142(20000715)89:2<328::AID-CNCR17>3.0.CO;2-F
    • Hainsworth JD, Burris HA 3rd, Litchy S et al (2000) Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial. Cancer 89:328-333 (Pubitemid 30489880)
    • (2000) Cancer , vol.89 , Issue.2 , pp. 328-333
    • Hainsworth, J.D.1    Burris III, H.A.2    Litchy, S.3    Morrissey, L.H.4    Barton, J.H.5    Bradof, J.E.6    Greco, F.A.7
  • 23
    • 34247877762 scopus 로고    scopus 로고
    • A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer
    • Lilenbaum R, Rubin M, Samuel J et al (2007) A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer. J Thorac Oncol 2:306-311
    • (2007) J. Thorac. Oncol. , vol.2 , pp. 306-311
    • Lilenbaum, R.1    Rubin, M.2    Samuel, J.3
  • 24
    • 9144262313 scopus 로고    scopus 로고
    • A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients
    • Ohe Y, Niho S, Kakinuma R et al (2004) A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients. Ann Oncol 15:45-50
    • (2004) Ann. Oncol. , vol.15 , pp. 45-50
    • Ohe, Y.1    Niho, S.2    Kakinuma, R.3
  • 25
    • 33750485379 scopus 로고    scopus 로고
    • Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials
    • Bria E, Cuppone F, Ciccarese M et al (2006) Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Cancer Treat Rev 32:583-587
    • (2006) Cancer Treat Rev. , vol.32 , pp. 583-587
    • Bria, E.1    Cuppone, F.2    Ciccarese, M.3
  • 27
    • 19944430496 scopus 로고    scopus 로고
    • A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the secondline treatment of non small cell lung cancer. The DISTAL 01 study
    • Gridelli C, Gallo C, Di Maio M et al (2004) A randomized clinical trial of two docetaxel regimens (weekly vs 3 week) in the secondline treatment of non small cell lung cancer. The DISTAL 01 study. Br J Cancer 91:1996-2004
    • (2004) Br. J. Cancer , vol.91 , pp. 1996-2004
    • Gridelli, C.1    Gallo, C.2    Di Maio, M.3
  • 28
    • 33644694366 scopus 로고    scopus 로고
    • Randomized phase III study of 3-weekly vs weekly docetaxel in pretreated advanced non-small-cell lung cancer: A Spanish lung cancer group trial
    • Camps C, Massuti B, Jiménez A et al (2006) Randomized phase III study of 3-weekly vs weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group Trial. Ann Oncol 47:467-472
    • (2006) Ann. Oncol. , vol.47 , pp. 467-472
    • Camps, C.1    Massuti, B.2    Jiménez, A.3
  • 29
    • 10744223982 scopus 로고    scopus 로고
    • Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    • Esteban E, González de Sande L, Fernández Y et al (2003) Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. Ann Oncol 14:1640-1647
    • (2003) Ann. Oncol. , vol.14 , pp. 1640-1647
    • Esteban, E.1    De Sande, G.L.2    Fernández, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.